← back to search

Tianyun Wang

Nankai University · CN
Area of research
Molecular Biology · Genetics
Research interest
Research interests include Viral Infectious Diseases and Gene Expression in Insects, Virus-based gene therapy research, CRISPR and Genetic Engineering, and Advanced SAR Imaging Techniques.
h-index
40
citations
5,819
works
307
NIH funding
primary concept
email

Recent publications

Efficient expression and functional verification of recombinant human type Ⅲ collagen in CHO cells.
2026cited by 0position: contributordoi
Cell Engineering for Increasing Production of Recombinant Proteins in Mammalian Cells.
2026cited by 0position: contributordoi
IGF2BP2 links m6A-modified HMGA1 mRNA stability to mitochondrial metabolism and cell proliferation
2026cited by 0position: contributordoi
From Cell Clones to Recombinant Protein Product Heterogeneity in Chinese Hamster Ovary Cell Systems.
2025cited by 2position: contributordoi
Effect of Apoptosis and Autophagy on Recombinant Protein Expression in Chinese Hamster Ovary Cells.
2025cited by 2position: contributordoi
Research Progress Fusion Tags for Recombinant Protein Production.
2025cited by 1position: contributordoi
Serum-free medium for recombinant protein expression in insect cells.
2025cited by 1position: contributordoi
Application of transposon expression system in recombinant protein expression and gene therapy.
2025cited by 0position: contributordoi
Recombinant therapeutic proteins degradation and overcoming strategies in CHO cells.
2024cited by 19position: contributordoi
Improvement strategies for transient gene expression in mammalian cells.
2024cited by 15position: contributordoi
Overexpression of YTHDF3 increases the specific productivity of the recombinant protein in CHO cells by promoting the translation process.
2024cited by 6position: contributordoi
Effect of Host Cell Protein on Chinese Hamster Ovary Recombinant Protein Production and its Removal Strategies: A Mini Review.
2024cited by 4position: contributordoi
Factors and Mechanism Affecting the Secretion of Recombinant Protein in CHO Cells
2024cited by 0position: contributordoi
Production of antibodies by perfusion culture of CHO cells
2024cited by 0position: contributordoi
Effects of 5'UTR characteristics on the recombinant protein expression in CHO cells
2024cited by 0position: contributordoi
Progress in fed-batch culture for recombinant protein production in CHO cells.
2023cited by 49position: contributordoi
Dual blockade of CD47 and CD24 signaling using a novel bispecific antibody fusion protein enhances macrophage immunotherapy.
2023cited by 22position: contributordoi
Apilimod enhances specific productivity in recombinant CHO cells through cell cycle arrest and mediation of autophagy.
2023cited by 11position: contributordoi
Effects and mechanism of small molecule additives on recombinant protein in CHO cells.
2023cited by 7position: contributordoi
Multifunctional calcium polyphenol networks reverse the hostile microenvironment of trauma for preventing postoperative peritoneal adhesions.
2023cited by 7position: contributordoi
Combination of MAR and intron increase transgene expression of episomal vectors in CHO cells.
2023cited by 1position: contributordoi
CMV/AAT promoter of MAR-based episomal vector enhanced transgene expression in human hepatic cells.
2023cited by 0position: contributordoi
Factors Affecting the Expression of Recombinant Protein and Improvement Strategies in Chinese Hamster Ovary Cells.
2022cited by 40position: contributordoi
Rare variants and the oligogenic architecture of autism
Trends in Genetics 2022cited by 34position: firstdoi
Increase recombinant antibody yields through optimizing vector design and production process in CHO cells.
2022cited by 26position: contributordoi
Screening Strategies for High-Yield Chinese Hamster Ovary Cell Clones.
2022cited by 23position: contributordoi
Discovering a new part of the phenotypic spectrum of Coffin-Siris syndrome in a fetal cohort
Genetics in Medicine 2022cited by 20position: middledoi
Progress of Transposon Vector System for Production of Recombinant Therapeutic Proteins in Mammalian Cells.
2022cited by 19position: contributordoi
Digitoxin promotes apoptosis and inhibits proliferation and migration by reducing HIF-1α and STAT3 in KRAS mutant human colon cancer cells.
2022cited by 17position: contributordoi
Enhanced Transgene Expression by Optimization of Poly A in Transfected CHO Cells.
2022cited by 15position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 30 papers (2019–2026)Yan‐long Jia · Xinxiang Medical University5 papers (2023–2026)Xiaoyin Wang · Xinxiang Medical University4 papers (2023–2025)Hui Guo · Central South University3 papers (2015–2020)Lu Xia · National Institute of Allergy and Infectious Diseases2 papers (2015–2017)Kun Xia · Nanchang University2 papers (2015–2017)Qi Tian · Shanghai University2 papers (2015–2017)Ying Li · Shandong Academy of Agricultural Sciences2 papers (2015–2017)Yanling Liu · Southwest Jiaotong University2 papers (2015–2017) · 2 papers (2015–2017)Zhiyuan Bai · 2 papers (2024–2024)Evan E. Eichler · Howard Hughes Medical Institute2 papers (2020–2022)Zhengmao Hu · Hunan University2 papers (2015–2017)Jinsong Gao · Brown University1 papers (2021–2021)Michael C. Zody · New York Genome Center1 papers (2020–2020) · 1 papers (2019–2019) · 1 papers (2021–2021)Su‐Mei He · Xuzhou Medical College1 papers (2021–2021)Marta Byrska-Bishop · New York Genome Center1 papers (2020–2020)Xuemin Jin · Zhengzhou University1 papers (2015–2015)